D'Amico Andrew sold $173K of VICR

D'Amico Andrew sold 531 shares of VICOR CORP (VICR) at an average of $326.04 ($319.53–$336.82, $0.17M total) across 2 trades over 2026-06-25 to 2026-06-26 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · D'Amico Andrew
Published Jun 29, 2026, 3:08 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 29, 2026, 3:13 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$VICR
Neutral
medium confidence
Mentioned
$VICR
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$VICRNeutralLow
01

Why it matters

The newest disclosed fact is the director’s open-market sale under a pre-arranged 10b5-1 plan, totaling ~$173.1K and resulting in 0 shares held.

02

Market read

Traders may monitor insider activity for sentiment, but this filing lacks any new business or financial catalyst.

03

What to watch

10b5-1 plans can be triggered regardless of near-term outlook; without context on prior holdings, the sale size may not reflect a change in fundamentals.

Relevance 3/10Novelty 5/10Timing: SEC Form 4 filed 2026-06-29 for trades dated 2026-06-25 to 2026-06-26

Background

The article is an SEC Form 4 insider transaction disclosure for ViCOR Corp (VICR).

Company-level read

Ticker impact

$VICRNeutralMedium confidence
Context

ViCOR Corp director Andrew D'Amico sold 531 shares in open-market trades (10b5-1) for ~$173.1K, leaving 0 shares.

Expected impact

Low likelihood of sustained price impact; any reaction is likely muted and short-lived.

Evidence & confidence

The filing is a Form 4 insider transaction and explicitly states a pre-arranged 10b5-1 plan; the article provides no new operational or financial developments.

Market effects

No sector read-through; this is company-specific insider selling with no accompanying guidance or regulatory action.

None indicated.

None indicated.

Counterpoint

A director fully exiting (0 shares after sale) could be interpreted by some traders as a stronger bearish signal despite the 10b5-1 label.

Key entities

  • VICOR CORP

    Company whose director insider sale is disclosed via SEC Form 4.

  • D'Amico Andrew

    Director who sold 531 shares under a Rule 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$VICRMed

VICR SWOT Analysis: Strong Revenue Growth and Patent Settlement

Vicor Corp (VICR) reported Q3 2026 revenue of $197.1M, up 78.5% YoY, driven by product sales and royalty revenue. Gross margin increased to 68.3%. The company has a strong order backlog of $406M but faces valuation concerns and customer concentration risks. It has growth opportunities in EVs and renewable energy. VICR's GF Score is 82/100, with high growth and profitability ratings but low valuation.

$VICRHigh

VICR Stock Surges On Blowout Q3 And Aggressive Capacity Bet

Vicor Corporation (VICR) stock rose 12.95% after reporting Q3 2026 revenue of $197.1M, up 78.5% YoY, with gross margin at 68.3%. The company's backlog and operating cash flow increased, driven by AI and high-performance systems demand. VICR is expanding capacity and faces an ITC investigation. Analysts raised price targets to $350-$360.

$VICRHighAI 8/10

Why is Vicor stock climbing today?

Vicor Corporation (VICR) stock rose 2.6% in morning trading, extending gains after its Q3 2026 earnings beat expectations. Revenue was $197.1M, up 78.5% YoY, with adjusted EPS of $1.33. Gross margin expanded to 68.3%, and the order backlog grew 166% YoY to $406M. Analysts maintained Buy ratings with price targets of $350 and $375. The stock traded at $209.36, above its 52-week low of $79 but below its high of $382.65.